Ralph Zagha, MD
Urology · Lauderdale Lakes, FLNPI 1063450773
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for urology clinicians in FL, where the typical reported total is $3,881.
Across 141 payments — averaging $28.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$478
- Johnson & Johnson$451
- Rochester Medical Corporation$441
- Myriad Genetic Laboratories, Inc.$301
- Astellas Pharma US Inc$166
- Verity Pharmaceuticals Inc.$164
- plus $2K from 31 others
Across 55 payments — averaging $8278.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- IBSA Institut Biochimique SA$322K
- Ironwood Pharmaceuticals, Inc$60K
- Urovant Sciences Inc$57K
- Sumitomo Pharma America, Inc.$10K
- AbbVie$6K
What the payments were for
- Food & beverage$3,93497%
- Education$1403%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 9 | $478 |
| Johnson & Johnson(3 entities) | 12 | $451 |
| Rochester Medical Corporation | 8 | $441 |
| Myriad Genetic Laboratories, Inc. | 11 | $301 |
| Astellas Pharma US Inc | 4 | $166 |
| Verity Pharmaceuticals Inc. | 7 | $164 |
| Endo Pharmaceuticals Inc. | 10 | $161 |
| AbbVie(2 entities) | 8 | $156 |
| Boston Scientific | 2 | $154 |
| Coloplast | 8 | $140 |
| Amgen | 5 | $134 |
| Terumo Medical Corporation | 1 | $132 |
| Endo USA, Inc. | 5 | $123 |
| Olympus America Inc. | 7 | $111 |
| Antares Pharma, Inc. | 6 | $104 |
| Lilly USA, LLC | 2 | $91 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $71 |
| Urogen Pharma, Inc. | 3 | $69 |
| 180 Medical, Inc. | 2 | $64 |
| Regeneron Healthcare Solutions, Inc. | 3 | $63 |
| AstraZeneca | 2 | $53 |
| Teleflex LLC | 2 | $49 |
| UCB, Inc. | 2 | $45 |
| Pfizer | 2 | $44 |
| Incyte Corporation | 2 | $42 |
| Biofrontera Inc. | 2 | $37 |
| Sunovion Pharmaceuticals Inc. | 2 | $33 |
| Convatec Inc. | 2 | $32 |
| Davol Inc. | 1 | $30 |
| Boehringer Ingelheim | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Calyxo, Inc. | 1 | $17 |
| Bristol Myers Squibb | 1 | $17 |
| Tolmar, Inc. | 1 | $14 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $13 |
| Agiliti Surgical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$244
- rezum Generator$137
- HydroPearl$132
- Erleada$126
- AKEEGA$126
- AQUABEAM SYSTEM$125
- CERTUS 140 MICROWAVE ABLATION SYSTEM$114
How this compares
$4,074 in reported general payments places this provider in the 50th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrelstarTriptorelin Pamoate | 124 | $267,071 |
| MyrbetriqMirabegron | 284 | $178,281 |
| PremarinEstrogens, Conjugated | 30 | $13,062 |
| GemtesaVibegron | 14 | $9,775 |
| Finasteride | 596 | $6,440 |
| Tamsulosin Hcl | 621 | $5,405 |
| Testosterone | 24 | $4,608 |
| Tolterodine Tartrate ErTolterodine Tartrate | 29 | $3,474 |
| Oxybutynin Chloride ErOxybutynin Chloride | 137 | $1,895 |
| Tadalafil | 51 | $1,311 |
| Dutasteride | 21 | $1,265 |
| Methenamine Hippurate | 44 | $1,265 |
| Testosterone Cypionate | 47 | $741 |
| Solifenacin Succinate | 23 | $739 |
| Bicalutamide | 18 | $376 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Verity Pharmaceuticals Inc.Trelstar | $164 | $267,071124 claims |
| Astellas Pharma US IncMyrbetriq | $166 | $178,281284 claims |
| PfizerPremarin | $44 | $13,06230 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $20 | $9,77514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 935 urology providers in Florida.
Other urology in Lauderdale Lakes
- Paul PeritoCoral Gables$3.6M
- Scott SellingerTallahassee$2.3M
- Mark Anthony GonzalgoMiami$1M
- Edward GheilerHialeah$655K
- Rolando RiveraNaples$437K
- Matthew ErcolaniVenice$416K
- Olubayo TojuolaOrlando$283K
- Juan SuarezCoral Gables$276K
- Michael McDonaldCelebration$272K
- Raymond PakJacksonville$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.